SCIENTIFIC ADVISORY COMMITTEE

RONNY.jpg

Professor Kristian Berg

Professor Kristian Berg is Head of Department of Radiation Biology, Institute for Cancer Research, Oslo University Hospital, since 2010. He graduated as biochemist in 1985 at the University of Oslo where he obtained his doctoral degree (dr.philos) in experimental photomedicine in 1990. He has 30 years of experience in experimental and preclinical research within the field photodynamic therapy (PDT).  He has a broad background in developing technologies from the bench via preclinical animal-based studies to the clinic and has contributed to establish two companies currently listed on the Oslo Stock Exchange with 2 products approved for clinical use and several in pipeline.

Professor Berg is an inventor of Photochemical Internalisation (PCI). He has received several prices such as Claude Rimingtons memorial prize, Pater-Leander-Fischer prize by Deutsche Gesellschaft für Lasermedizin,  Kendric C. Smith Innovation Lecture Award and European Society for Photobiology Award for Excellence in Photobiological Research. He is also an appointed Member of the Norwegian Academy of Science and Letters from 2014.  He has been President of the European Society for Photobiology (2007-2009), visiting professor at the Medical Faculty, University of Wroclaw, Poland, and professor at School of Pharmacy, University of Oslo from 2009. Professor Berg has published more than 200 papers, mainly in peer reviewed journals and is co-inventor of 8 patents.

Professor Ernst wagner

Prof. Wagner is a professor of Pharmaceutical Biotechnology at the Ludwig-Maximilians-Universität (LMU) and the Center of Nanoscience in Munich, Germany. Previously (1991-2001), he was the Director Cancer Vaccines & Gene Therapy at Boehringer Ingelheim in Vienna, Austria, where he supervised the first-in-world polymer-based human gene therapy trial in 1994. Prof. Wagner is an Academician of European Academy of Sciences, a member of the Controlled Release Society (CRS) College of Fellows, and a board member of German Society for Gene Therapy. Prof. Wagner has authored more than 485 publications with more than 45 000 citations. His current academic research projects focus on the targeted delivery of nucleic acids (including mRNA) and protein therapeutics.